Evidence map›Paper›PMID 24475029›Full record

ArticlePloS one2014

A novel complex A/C/G intergenotypic recombinant of hepatitis B virus isolated in southern China.

Heling Su, Yan Liu, Zhihui Xu, Shuquan Cheng, Haiyan Ye, Qing Xu, Qingbo Liu, Shuhong Tan, Dongping Xu, Yongming Liu

Abstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Heling SuDepartment of Biochemistry and Molecular Biology, Guilin Medical University, Guilin, Guangxi, China.
Yan LiuViral Hepatitis Research Laboratory, Institute of Infectious Diseases/Liver Failure Medical Center, Beijing 302 Hospital, Beijing, China.
Zhihui XuViral Hepatitis Research Laboratory, Institute of Infectious Diseases/Liver Failure Medical Center, Beijing 302 Hospital, Beijing, China.
Shuquan ChengDivision of Hepatology, The Third People's Hospital of Guilin, Guilin, Guangxi, China.
Haiyan YeDivision of Hepatology, The Third People's Hospital of Guilin, Guilin, Guangxi, China.
Qing XuGuangxi Key Laboratory of Molecular Medicine in Liver Injury and Repair, Guilin Medical University, Guilin, Guangxi, China.
Qingbo LiuDepartment of Biochemistry and Molecular Biology, Guilin Medical University, Guilin, Guangxi, China.
Shuhong TanDepartment of Biochemistry and Molecular Biology, Guilin Medical University, Guilin, Guangxi, China.
Dongping XuViral Hepatitis Research Laboratory, Institute of Infectious Diseases/Liver Failure Medical Center, Beijing 302 Hospital, Beijing, China.
Yongming LiuDepartment of Biochemistry and Molecular Biology, Guilin Medical University, Guilin, Guangxi, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatitis B virus (HBV) genotypes and subgenotypes may vary in geographical distribution and virological features. Previous investigations, including ours, showed that HBV genotypes B and C were respectively predominant in South and North China, while genotypes A and D were infrequently detected and genotype G was not found. In this study, a novel A/C/G intergenotype was identified in patients with chronic HBV infection in Guilin, a city in southern China. Initial phylogenetic analysis based on the S gene suggested the HBV recombinant to be genotype G. However, extended genotyping based on the entire HBV genome indicated it to be an A/C/G intergenotype with a closer relation to genotype C. Breakpoint analysis using the SIMPLOT program revealed that the recombinant had a recombination with a arrangement of genotypes A, G, A and C fragments. Compared with the HBV recombinants harboring one or two genotype G fragments found in Asian countries, this Guilin recombinant was highly similar to the Vietnam (98-99%) and Long An recombinants (96-99%), but had a relatively low similarity to the Thailand one (89%). Unlike those with the typical genotype G of HBV, the patients with the Guilin recombinant were seropositive for HBeAg. Moreover, a relatively high HBV DNA viral load (>2 × 10(6) IU/ml) was detected in the patients, and the analysis of viral replication capacity showed that the Guilin recombinant strains had a competent replication capacity similar to genotypes B and C strains. These findings can aid in not only the clarification of the phylogenetic origin of the HBV recombinants with the genotype G fragment found in Asian countries, but also the understanding of the virological properties of these complicated HBV recombinants.

Indexed as

GenotypeRecombination, GeneticAdultChinaCloning, MolecularEvolution, MolecularFemaleGenome, ViralHepatitis B Surface AntigensHepatitis B virusHumansMaleMolecular Sequence DataPhylogenyReassortant VirusesYoung AdultHepatitis B Surface Antigens

Identifiers

PMID24475029
PMCPMC3901648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.